100% tariff threat looms over patented drugs; generics exempt for now

100% tariff threat looms over patented drugs; generics exempt for now

The Trump administration has outlined a sweeping tariff framework targeting patented pharmaceutical products, while offering near-term relief to generic drugmakers. A 100% tariff on patented pharmaceutical products has been proposed, with implementation timelines of 120 days for large companies and 180 days for smaller firms. However, products sourced from regions such as the EU, Japan,…

Read More